If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
479.40    1.40 (0.29%)
Bid:
481.20
Ask:
482.00
Spread: 0.80 (0.166%)
Market Cap: £2.46b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

LTPA Extension

22 May 2025 07:01

RNS Number : 6880J
QinetiQ Group plc
22 May 2025
 

News release

QinetiQ Group plc

LTPA extension worth £1.54 billion to modernise test & evaluation for future warfare

22 May 2025 - QinetiQ Group plc ("QinetiQ") today announces a five-year, £1.54 billion extension to its Long Term Partnering Agreement (LTPA) with the UK's Ministry of Defence (MOD) that will transform the provision of mission critical test and evaluation capabilities and services that help to enhance operational readiness of the UK and allied nations.

Alongside the contract amendment extending the LTPA to 2033, the Company is also recognising an incremental order of £166 million relating to current investments in test and evaluation.

Through the LTPA, QinetiQ delivers vital Test, Trials, Training and Evaluation (T3E) capabilities that ensure armed forces personnel are equipped and prepared for mission success. Over the next eight years, QinetiQ and the MOD will continue to invest to deliver T3E for next generation defence technologies such as uncrewed systems, hypersonics and directed energy weapons. Digitalisation will increase the pace at which new concepts and solutions are tested and then delivered into service. QinetiQ and the MOD have committed to improve access for agile and innovative small and medium sized enterprises (SMEs) to use the LTPA's services.

Defence Secretary John Healey MP said: "Rigorously tested equipment and the trialling of emerging technologies are key to ensuring our armed forces are using combat-ready capabilities on the frontline.

"The contract will help keep Britain secure at home and strong abroad, as we drive forward innovation to bolster our national security and support skilled jobs across the UK.

"With hundreds of British businesses supported by this investment through QinetiQ's supply chain, we are demonstrating how defence is an engine for growth across the UK, and delivering on our Plan for Change."

Steve Wadey, Group Chief Executive Officer at QinetiQ, said: "Through the LTPA, we play a vital role helping to protect and enhance the UK's defence and security. The extension of our partnership with MOD enables us to continue investing to deliver the transformational change in test and evaluation that's required to ensure our armed forces have operational advantage over disruptive technologies.

"We're seeing increased demand for our services from NATO countries and this LTPA extension positions the UK as a leading centre for T3E and facilitates the delivery of major equipment platforms as well as future upgrade programmes."

The extension to the LTPA will sustain more than 1,200 highly skilled jobs at 16 MOD sites across England, Scotland and Wales and support an increasingly diverse supply chain of more than 825 companies across the UK, 590 of which are SMEs.

Earlier this month, QinetiQ hosted Formidable Shield, a NATO joint strike exercise, at the MOD Hebrides range - one of 16 sovereign sites managed under the LTPA.

Since the signing of the original 25-year contract in 2003, QinetiQ, in partnership with MOD, has delivered T3E services which have supported crucial moments in UK defence. These include the first launch of a ballistic rocket into space from the UK, the UK's first firing of a high-power laser directed energy weapon against aerial targets and Europe's first successful demonstration of teaming a piloted aircraft with an autonomous air vehicle. The extension will support the delivery of a range of future defence capability including the Global Combat Air Programme (GCAP), Dreadnought nuclear submarines as well as drones.

 

For further information, please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Stephanie Mann, Group Head of Media Relations (Media enquiries): +44 (0) 7770 720268

 

About QinetiQ

 

QinetiQ is an integrated global defence and security company focused on mission-led innovation. Our purpose is protecting lives by serving the national security interests of our customers. We employ more than 8,500 highly-skilled people, committed to creating new ways of testing technologies, systems, and processes to make sure they meet operational needs, and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

Visit www.QinetiQ.com for more information, or follow us on LinkedIn.

About LTPA

The Long Term Partnering Agreement (LTPA) is a strategic framework contract originally signed in 2003, between QinetiQ and the UK Ministry of Defence, delivering Test, Trials, Training and Evaluation services through 16 core MOD-owned sites in England, Scotland and Wales.

 

Under the LTPA, QinetiQ supports the UK MOD - and its allies - in ensuring Land, Maritime and Air assets, as well as weapons capabilities, meet the frontline's requirements, through investment in new technology, facilities and operating models.

 

Visit www.t3e.uk for more information.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAAARVNUVUUR
Date   Source Headline
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.